Skip to main content
Bavarian Nordic logo

Bavarian Nordic — Investor Relations & Filings

Ticker · BAVA ISIN · DK0015998017 LEI · 2138006JCDVYIN6INP51 CO Manufacturing
Open in API
Filings indexed 2,293 across all filing types
Latest filing 2026-05-13 Director's Dealing
Country DK Denmark
Listing CO BAVA

About Bavarian Nordic

https://www.bavarian-nordic.com/

Bavarian Nordic is a fully integrated biotechnology company specializing in the research, development, manufacturing, and commercialization of life-saving vaccines. The company's portfolio targets infectious diseases, including vaccines for Mpox, rabies, and typhoid. It is a leading global provider of travel vaccines and serves as a key partner for governments and international organizations in addressing public health preparedness needs.

Recent filings

Filing Released Lang Actions
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing Classification · 95% confidence The document is a company announcement under EU Regulation 596/2014 disclosing share transactions by board members and other persons discharging managerial responsibilities. It lists individual insider trades (restricted stock units converted to shares) by directors and is not a financial report, earnings release, or dividend notice. This fits the ‘Director’s Dealing’ category.
2026-05-13 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing Classification · 98% confidence The document is a mandatory disclosure under EU Regulation (EU) No. 596/2014 concerning transactions in the company’s shares by leading employees and their related parties. It lists multiple insider transactions (Restricted Stock Units transfers) by board members, detailing dates, quantities, prices, and instrument identifiers. This corresponds exactly to a report of insider/director share dealings.
2026-05-13 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing Classification · 95% confidence The document is a public announcement detailing transactions of company shares by persons holding managerial responsibilities or their close associates, including board members, under Article 19 of the Market Abuse Regulation. It exactly matches insider trading disclosures by directors (vesting of restricted stock units). Thus it is classified as a Director’s Dealing report.
2026-05-13 English
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing Classification · 95% confidence The document details the transactions of shares/related securities by persons holding managerial responsibilities (board members) in accordance with Article 19 of Regulation 596/2014. It is reporting acquisitions (vesting of RSUs) by insiders, which falls under insider transactions. Therefore, it is a Director’s Dealing filing.
2026-05-13 English
Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox Vaccines
Regulatory Filings Classification · 85% confidence The document is a company announcement (“Selskabsmeddelelse”) disclosing a contract award by the U.S. government and an update to its full‐year revenue and EBITDA guidance. It does not contain audited financial statements or detailed interim results, nor is it announcing a formal report publication, dividend, share issue, management change, or merger transaction. It is therefore a general regulatory announcement and best fits the fallback category Regulatory Filings (RNS).
2026-05-11 Danish
Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox Vaccines
Regulatory Filings Classification · 94% confidence The document is a corporate press release announcing a new government contract award and guidance update. It does not contain full financial statements or earnings results, nor is it an AGM presentation, investor presentation, or formal report (Annual/Interim). It is an ad hoc company announcement providing business updates and guidance revisions. This does not match any specialized categories like Earnings Release, Interim Report, or Financing Update. Therefore, it falls into the fallback “Regulatory Filings” category (RNS).
2026-05-11 Danish

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.